Daiichi Sankyo (OTCMKTS:DSNKY) Shares Gap Down – Here’s What Happened

by · The Cerbat Gem

Shares of Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKYGet Free Report) gapped down before the market opened on Tuesday . The stock had previously closed at $24.60, but opened at $23.20. Daiichi Sankyo shares last traded at $23.93, with a volume of 24,004 shares traded.

Wall Street Analysts Forecast Growth

Separately, Zacks Research downgraded shares of Daiichi Sankyo from a “hold” rating to a “strong sell” rating in a research note on Wednesday, November 19th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Daiichi Sankyo has an average rating of “Moderate Buy”.

Get Our Latest Stock Report on Daiichi Sankyo

Daiichi Sankyo Trading Down 2.7%

The firm’s 50-day simple moving average is $24.35 and its 200 day simple moving average is $24.38. The company has a debt-to-equity ratio of 0.06, a current ratio of 2.31 and a quick ratio of 1.60. The firm has a market capitalization of $45.03 billion and a price-to-earnings ratio of 22.42.

Daiichi Sankyo Company Profile

(Get Free Report)

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.

Recommended Stories